Meeting Program
 |
To view program in "24 hour" time (international) click here. |
| Sunday, March 22 | ||
|---|---|---|
| 3:00 - 7:30 PM | Registration | Longs Peak Foyer |
| 6:30 - 7:30 PM | Refreshments | Longs Peak Foyer |
| 7:30 - 9:30 PM |
Keynote Address (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak / Longs Peak |
|
Francoise Barré-Sinoussi,
Institut Pasteur, France
HIV Diversity and Pathogenesis |
||
|
Rafi Ahmed,
Emory University School of Medicine, USA
Talk Title to be Determined |
||
| Monday, March 23 | ||
| 7:00 - 8:00 AM | Breakfast | Red Cloud / Shavano / Torreys |
| 8:00 - 11:00 AM |
Host Genomics and HIV Disease (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak / Longs Peak |
|
Amalio Telenti,
Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland
Genomics and Vaccine Strategies |
||
|
Mary Carrington,
National Cancer Institute, National Institutes of Health, USA
Immunogenetics |
||
|
Bruce D. Walker,
Massachusetts General Hospital, USA
Genomics of Long-Term Progressors |
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 9:20 - 9:40 AM | Coffee Break | Longs Peak Foyer |
| 11:00 AM- 1:00 PM | Poster Setup | Red Cloud / Shavano / Torreys |
| 11:00 AM- | On Own for Lunch | |
| 1:00 - 10:00 PM | Poster Viewing | Red Cloud / Shavano / Torreys |
| 4:30 - 5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00 - 7:00 PM |
Hiding from Immunity: Reservoirs and Latency Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak |
|
Robert F. Siliciano,
Johns Hopkins School of Medicine, USA
Quantitative Analysis of the Control of HIV Replication by Drugs and Vaccines |
||
|
Joel Nee-lartey Blankson,
Johns Hopkins School of Medicine, USA
HIV Control in Elite Suppressors |
||
|
Dana H. Gabuzda,
Dana Farber Cancer Institute, USA
Macrophage Reservoirs |
||
| Following Session is for Prevention of HIV/AIDS (X3) | ||
| 5:00 - 7:00 PM |
The Bigger Picture: Microbicides, Circumcision and Drugs for Prevention Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Longs Peak |
|
Melissa J. Robbiani (Pope),
Population Council, USA
Science of Microbicide Development |
||
|
Bertran Auvert,
CHU Ambroise Paré, France
Circumcision: Uptake and Impact |
||
|
Myron S. Cohen,
University of North Carolina at Chapel Hill, USA
ART for Prevention of the Sexual HIV Transmission of HIV |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Red Cloud / Shavano / Torreys |
| 7:30 - 10:00 PM |
Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Red Cloud / Shavano / Torreys |
| Tuesday, March 24 | ||
| 7:00 - 8:00 AM | Breakfast | Red Cloud / Shavano / Torreys |
| 8:00 - 11:00 AM |
Immune Control of HIV and Virus Escape (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak / Longs Peak |
|
Francine E. McCutchan,
USMHRP/Henry M. Jackson Foundation, USA
Molecular Complexity of the Epidemic |
||
|
Philip J. Goulder,
University of Oxford, UK
HIV Escape and T Cell Control of HIV |
||
|
Giuseppe Pantaleo,
Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland
Immune Correlates of Protection to HIV |
||
|
George M. Shaw,
University of Alabama at Birmingham, USA
HIV Escape to Antibodies |
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 9:20 - 9:40 AM | Coffee Break | Longs Peak Foyer |
| 11:00 AM- 1:00 PM | Poster Setup | Red Cloud / Shavano / Torreys |
| 11:00 AM- | On Own for Lunch | |
| 1:00 - 10:00 PM | Poster Viewing | Red Cloud / Shavano / Torreys |
| 2:30 - 4:30 PM |
Workshop: New Therapeutics |
Grays Peak |
|
Daria J. Hazuda,
Merck Research Laboratories, USA
Integrase Inhibitors |
||
|
Mike Westby†,
Pfizer Global Research and Development, UK
Entry Inhibitors |
||
|
Navid Madani,
Dana Farber Cancer Institute, USA
New Entry Inhibitors: Interaction of Small-Molecule CD4 Mimics with a Highly Conserved Pocket on the HIV gp120 Envelope Glycoprotein |
||
| 4:30 - 5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00 - 7:00 PM |
Models of HIV Immunobiology Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak |
|
Guido Silvestri,
University of Pennsylvania School of Medicine, USA
SIV Infection of African Monkeys: A New Paradigm for AIDS Pathogenesis |
||
|
Cecilia Cheng-Mayer,
Aaron Diamond AIDS Research Center, USA
Coreceptor Switching in the SHIV/Macaque Model |
||
|
Sarah L. Rowland-Jones,
MRC Laboratories, the Gambia, Gambia
Lessons from HIV-2 |
||
| Following Session is for Prevention of HIV/AIDS (X3) | ||
| 5:00 - 7:00 PM |
How to Improve Vaccine Efficacy? Adjuvants, Route of Administration... Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Longs Peak / Grays Peak |
|
Bali Pulendran,
Emory University, USA
Modulating Vaccine Responses with Innate Immunity |
||
|
Christopher J. Miller,
University of California, Davis, USA
Intra-Nasal/-Vaginal Mucosal Immunization |
||
|
Susan W. Barnett,
Chiron Corporation, USA
Mucosal Antibodies and Systemic Vaccine |
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Red Cloud / Shavano / Torreys |
| 7:30 - 10:00 PM |
Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Red Cloud / Shavano / Torreys |
| Wednesday, March 25 | ||
| 7:00 - 8:00 AM | Breakfast | Red Cloud / Shavano / Torreys |
| 8:00 - 11:00 AM |
New Insights in HIV Replication Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak |
|
Frank Kirchhoff,
University of Ulm, Germany
Role of Nef in vivo and in vitro |
||
|
Speaker to be Announced,
|
||
|
Christopher Aiken,
Vanderbilt University School of Medicine, USA
Cyclophilin A and HIV-1 Capsid Function |
||
|
Nathaniel R. Landau†,
NYU School of Medicine, USA
Vpr and DNA Damage |
||
| Following Session is for Prevention of HIV/AIDS (X3) | ||
| 8:00 - 11:00 AM |
How to Generate Vaccine Efficacy against HIV? T Cell-Based and B-Cell Based Vaccines Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Longs Peak |
|
Barton F. Haynes,
Duke University Medical Center, USA
Keynote Address: What Does a Successful HIV-1 Vaccine Need To Do? Clues from Acute HIV Infection |
||
|
Dan H. Barouch,
Beth Israel Deaconess Medical Center, USA
Novel Adenovirus T Cell-Based Vaccines for HIV |
||
|
Dennis R. Burton,
The Scripps Research Institute, USA
Mechanisms of Antibody Protection Against HIV |
||
|
Peter D. Kwong,
National Institutes of Health, USA
Structure-Based Envelope Immunogens |
||
| 9:20 - 9:40 AM | Coffee Break | Longs Peak Foyer |
| 11:00 AM- 1:00 PM | Poster Setup | Red Cloud / Shavano / Torreys |
| 11:00 AM- | On Own for Lunch | |
| 1:00 - 10:00 PM | Poster Viewing | Red Cloud / Shavano / Torreys |
| 1:30 - 4:30 PM |
NIAID Workshop on HIV Co-Factors/Restriction Factors NOTE: The objective of the workshop will be to discuss the current status of the field; determine the best approach for validating the mechanism of action of host molecules in primary cells; and, promote development of assays which recreate the activity of a cellular co-factor, or a cellular restriction, with the goal of producing a high throughput screening assay for testing chemical compound libraries. |
Grays Peak |
|
*
Opendra K. Sharma,
NIAID, National Institutes of Health, USA
|
||
|
*
Roger Miller,
NIAID, National Institutes of Health, USA
|
||
|
Speakers to be Announced,
|
||
| 4:30 - 5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00 - 7:00 PM |
HIV at the Mucosa: Portal of Entry and Front-Line Defense (Joint) Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak / Longs Peak |
|
Ashley T. Haase,
University of Minnesota, USA
Keynote Address: HIV at Mucosal Front Lines |
||
|
Ronald S. Veazey,
Tulane National Primate Research Center, USA
HIV and Intestinal Lymphoid Tissue |
||
|
Alison Simmons,
Weatherall Institute of Molecular Medicine, UK
HIV and Dendritic Cell Activation |
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Red Cloud / Shavano / Torreys |
| 7:30 - 10:00 PM |
Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Red Cloud / Shavano / Torreys |
| Thursday, March 26 | ||
| 7:00 - 8:00 AM | Breakfast | Red Cloud / Shavano / Torreys |
| 8:00 - 11:00 AM |
Innate Antiviral Immunity Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak |
|
Michael H. Malim,
King's College London School of Medicine, UK
Antiviral Cytidine Deaminases |
||
|
Warner C. Greene,
Gladstone Institute of Virology and Immunology, USA
APOBEC and Early Block to HIV Infection |
||
|
Greg J. Towers,
University College London, UK
Talk Title to be Determined |
||
|
Paul D. Bieniasz,
Aaron Diamond AIDS Research Center, USA
Post-Entry Blocks |
||
| Following Session is for Prevention of HIV/AIDS (X3) | ||
| 8:00 - 11:00 AM |
Lessons from Clinical Trials of Preventative Vaccines Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Longs Peak |
|
Scott M. Hammer,
Columbia University, USA
Keynote Address: Challenges in Preventative Vaccine Development |
||
|
Speaker to be Announced,
|
||
|
M. Juliana McElrath,
Fred Hutchinson Cancer Research Center, USA
Lessons from the HIV-Ad5 Vaccine Phase II Clinical Trial |
||
|
Merlin L. Robb†,
Walter Reed Army Institute of Research, USA
Results from the HIV-Canarypox Vaccine Phase III Clinical Trial |
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 9:20 - 9:40 AM | Coffee Break | Longs Peak Foyer |
| 11:00 AM- | On Own for Lunch | |
| 4:30 - 5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00 - 7:00 PM |
Virus Spread Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Grays Peak |
|
Olivier Schwartz,
Institut Pasteur, France
T Cell-T Cell Transfer |
||
|
Thomas J. Hope,
Northwestern University, Feinberg School of Medicine, USA
Visualizing the Infectious Synapse |
||
|
Vincent Piguet,
University Hospital of Geneva, Switzerland
Mechanisms of DC-T Cell HIV-1 Transmission via an Infectious Synapse |
||
| Following Session is for Prevention of HIV/AIDS (X3) | ||
| 5:00 - 7:00 PM |
Prevention of AIDS: What can we Learn from Therapeutic Vaccines? Registered attendees for this meeting can view Abstracts for this session starting on 02/22/2009 |
Longs Peak |
|
Brigitte Autran,
Hôpital Pitié-Salpétrière, UPMC, France
Lessons for Therapeutic Vaccines against HIV for Immune Correlates of Protection against HIV |
||
|
Susan P. Buchbinder†,
San Francisco Department of Public Health, USA
Comparison between Preventative and Therapeutic Vaccine Trials using Adenovirus 5 Vectors |
||
|
Speaker to be Announced,
|
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Red Cloud / Shavano / Torreys |
| 8:00 - 11:00 PM | Entertainment | Red Cloud / Shavano / Torreys |
| Friday, March 27 | ||
| Departure | ||
| *=Session Chair †=Speaker invited, not yet responded. | ||
Keystone Symposia would like to thank the sponsor of this meeting for their generous support:
We gratefully acknowledge additional support for this conference from:
 |
GenVec, Inc. |
We gratefully acknowledge the companies that provide Keystone Symposia with additional meeting support, including marketing and advertising...
Click here to view these companies